|
Skeletal muscle loss under chemotherapy and its association with survival and systemic treatment toxicity in metastatic colorectal cancer: An AGEO prospective multicenter study. |
| |
|
Consulting or Advisory Role - Sanofi; SERVIER |
Travel, Accommodations, Expenses - Amgen |
| |
|
No Relationships to Disclose |
| |
|
|
Travel, Accommodations, Expenses - Mundipharma |
| |
|
Honoraria - Bristol-Myers Squibb; SERVIER |
Consulting or Advisory Role - Amgen; Baxter; Bayer; Merck; Pierre Fabre; Roche; SERVIER |
Travel, Accommodations, Expenses - Merck; Roche; SERVIER |
| |
|
No Relationships to Disclose |
| |
|
Honoraria - Sanofi; SERVIER |
Consulting or Advisory Role - Amgen; Merck; Sanofi; SERVIER |
Travel, Accommodations, Expenses - Amgen; SERVIER |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
Research Funding - Merck (Inst) |
Travel, Accommodations, Expenses - Amgen; Celgene; Merck |
| |
|
Honoraria - Amgen; AstraZeneca; Merck Serono; Sanofi |
Consulting or Advisory Role - Amgen; Merck Serono; Pierre Fabre |
Travel, Accommodations, Expenses - Amgen; Roche; Servier/Pfizer |
| |
|
Consulting or Advisory Role - Norgine |
| |
|
Consulting or Advisory Role - Amgen; Celgene; Lilly; Merck KGaA; MSD; Pierre Fabre; Roche; SERVIER; Sirtex Medical |
Speakers' Bureau - Amgen; Lilly; Merck; MSD; Pierre Fabre; Roche/Genentech; Sanofi; SERVIER |